Nov 16, 2026
India is one of the fastest-growing markets for medical devices. Yet for most European manufacturers, the costly mistakes happen long before the first sale, and almost all of them are avoidable.
We see the same three, again and again:
- The wrong CDSCO classification: Misclassify your device and you refile from scratch. Every deficiency query adds weeks, sometimes months and because a foreign manufacturer cannot hold Indian import licences on its own, the wrong Authorised Agent can leave your registrations tied to a distributor you don't control.
- Market-entry decisions made too late: Entity, tax and compliance choices made after launch are expensive to unwind, especially when regulatory, legal and tax advice come from three different firms and no one owns the full plan.
- Signing the first distributor who replies: Partners are hard to vet from abroad. Many companies sign quickly, then discover gaps in reach, in regulatory capability, or an exclusivity clause they can't exit.
Meet our Team at MEDICA, DÜSSELDORF on 16 and 17 November 2026
15 Minutes AT MEDICA & You'll walk away knowing:
- Your CDSCO risk class, approval route and a realistic timeline
- How to set up your Authorised Agent so registrations stay in your hands
- The right entry model for your stage: subsidiary, agent or distributor-led
- Whether the distributor you're talking to is the right one
No sales pitch, just straight answers from the people who do this every day.
Write to naina.bhardwaj@dezshira.com with your preferred day and time. We'll confirm your slot and meeting point by return.
Slots going first come, first served, and they are filling fast.
See you in Düsseldorf, Germany.
location
In-person | MEDICA, Düsseldorf, Germany | 16-19 November 2026
Speaker
